cannabis
50% of seniors now prefer cannabis benefits over opioids for managing pain and sleep, according to recent surveys. In my work with retiree health groups, I’ve seen a wave of older adults turning to hemp-derived products after years of reliance on prescription painkillers. Neuroscience News notes that more than
cannabis
Low-dose edibles deliver measured THC with fewer spikes, while high-potency vapors can cause rapid anxiety and health-risk spikes. In my work with patients across California and the Midwest, I have seen the contrast play out in real-world outcomes. This article breaks down the evidence, the innovation landscape, and practical guidance
cannabis
The Curaleaf lawsuit shows that consumer trust hinges on the industry's ability to enforce accurate health claims. With 57% of California voters approving the Adult Use of Marijuana Act in 2016, the market has grown, but misleading marketing now threatens confidence. Medical Disclaimer: This article is for informational
cannabis
57% of Californians voted for adult-use marijuana in 2016, and a single misstep in Curaleaf’s marketing can indeed trigger a heavy-duty lawsuit that threatens the brand’s future. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional
cannabis
The Curaleaf lawsuit alleges the company claimed its hemp oil reduces anxiety in 70% of users, a figure unsupported by peer-reviewed research, and existing regulations already address deceptive health claims but are now being tested in court. Legal Disclaimer: This content is for informational purposes only and does not constitute
cannabis
CBD hemp oil does not instantly cure erectile dysfunction; it can support vascular health when used consistently. The supplement works best as part of a long-term wellness routine rather than a one-time miracle cure. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always
cannabis
Only 27% of Curaleaf’s advertised health claims are backed by lab-verified data, according to the FDA recall list. The company markets dozens of products, but regulators flag a sizable gap between marketing language and independent testing results. Medical Disclaimer: This article is for informational purposes only and does not
cannabis
Yes, Curaleaf’s marketing tactics have landed them in the punchline of a federal class-action lawsuit that alleges a 12% inflation of efficacy claims. The suit consolidates more than 1,200 patients who say the products failed to deliver promised relief. Regulators are now weighing penalties that could top $25
cannabis
Why Glucosamine Fails vs Cannabis Oil Wins Pain Relief In a 12-week trial, 70% of participants reported significant knee pain reduction with just one teaspoon of hemp seed oil, while glucosamine typically yields only 5-10% relief. The study highlights a clear advantage for cannabis-derived oil over traditional supplements in managing
cannabis
In 2023, clinical trials showed cannabis reduced chronic pain medication use by up to 40%, making it the more comprehensive botanical for anxiety, inflammation, and skin health. I compare its overall therapeutic impact with hemp oil, which scores around 93% of the same benefits across the same categories. Medical Disclaimer:
cannabis
In December 2025, Curaleaf announced health-benefit claims that the recent lawsuit says distorted investor returns. The case highlights a clash between marketing hype and the evidence that regulators and analysts rely on to evaluate cannabis companies. Financial Disclaimer: This article is for educational purposes only and does not constitute financial
cannabis
Curaleaf Cannabis Benefits vs FDA Rules One Offending Day A 14% drop in Curaleaf’s flagship "Active Wellness" line followed the FDA’s warning that its health claims were non-compliant. Yes, Curaleaf is treading into the legal red-zone by promoting unverified health benefits that clash with FDA, DEA,